Education
About Us
Working with TipRanks
Follow Us
Lightbridge (LTBR)
NASDAQ:LTBR
LTBR Stock Chart & Stats
$15.17
-$0.50(-8.68%)
At close: 4:00 PM EST
$15.17
-$0.50(-8.68%)
Day’s Range― - ―
52-Week Range$6.10 - $31.34
Previous CloseN/A
Volume503.45K
Average Volume (3M)812.88K
Market Cap
$353.13M
Enterprise Value$66.08M
Total Cash (Recent Filing)$201.86M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.54
Next Earnings
May 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding34,152,060
10 Day Avg. Volume973,255
30 Day Avg. Volume812,883
Financial Highlights & Ratios
PEG Ratio12.82
Price to Book (P/B)1.53
Price to Sales (P/S)0.00
P/FCF Ratio-21.70
Enterprise Value/Market Cap0.19
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-3.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Cash RunwayA ~$201.9M cash balance funded largely by $176M of net proceeds creates multi-year runway to execute irradiation, qualification and scale-up activities without near-term refinancing. This materially reduces funding risk and lets management follow a milestone-driven program aligned with licensing timelines.
Technical Milestones & ATR TestingCommencement of ATR irradiation and prior fabrication milestones (co-extrusion coupons and FAST method) generate regulator-relevant data and validate manufacturing approaches. These are durable, structural de-risking events that underpin licensing dossiers and increase the likelihood of eventual commercial adoption by fabricators and utilities.
Debt-free Capital StructureA debt-free balance sheet preserves financial flexibility, avoids fixed interest obligations, and reduces leverage-related constraints on R&D. Combined with rising interest income on cash holdings, this supports disciplined, milestone-linked capital allocation and lowers refinancing risk while the business remains pre-commercial.
Bears Say
Pre-commercial — No RevenueNo reported product or licensing revenue means the technology has not yet been monetized, leaving the company dependent on capital markets and partner funding until licensing and commercial fabricator adoption occur. This structural lack of revenue keeps profitability and self-funding distant risks.
Persistent Cash BurnOperating and free cash flow have been negative consistently, with 2025 cash use rising to -$14.3M. Sustained burn to fund R&D, testing and team expansion means management must preserve runway or raise additional capital before revenues, creating execution and dilution risk despite current cash balances.
Regulatory & Qualification Timing RiskRegulatory review, NRC engagement and post-irradiation examinations are prerequisites for commercialization and can take many months to years. The absence of initiated formal NRC interaction and pending qualification work represent structural timeline and execution risk that will govern revenue timing and partner uptake.
Lightbridge News
LTBR FAQ
What was Lightbridge’s price range in the past 12 months?
Lightbridge lowest stock price was $6.10 and its highest was $31.34 in the past 12 months.
What is Lightbridge’s market cap?
Lightbridge’s market cap is $353.13M.
When is Lightbridge’s upcoming earnings report date?
Lightbridge’s upcoming earnings report date is May 13, 2026 which is in 51 days.
How were Lightbridge’s earnings last quarter?
Lightbridge released its earnings results on Feb 25, 2026. The company reported -$0.215 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.215.
Is Lightbridge overvalued?
According to Wall Street analysts Lightbridge’s price is currently Overvalued.
Does Lightbridge pay dividends?
Lightbridge does not currently pay dividends.
What is Lightbridge’s EPS estimate?
Lightbridge’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lightbridge have?
Lightbridge has 34,152,060 shares outstanding.
What happened to Lightbridge’s price movement after its last earnings report?
Lightbridge reported an EPS of -$0.215 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.653%.
Which hedge fund is a major shareholder of Lightbridge?
Currently, no hedge funds are holding shares in LTBR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lightbridge Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 398.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
9.76%
12-Months-Change
Fundamentals
Return on Equity
-15.31%
Trailing 12-Months
Asset Growth
397.73%
Trailing 12-Months
Company Description
Lightbridge
Lightbridge Corporation, together with its subsidiaries, engages in the design and development of nuclear fuel technology under the Lightbridge Fuel name. It focuses on developing and commercializing metallic nuclear fuels that could enhance resistance of nuclear fuel in existing and new nuclear reactors with a meaningful impact on addressing climate change and air pollution. The company was formerly known as Thorium Power, Ltd. and changed its name to Lightbridge Corporation in September 2009. Lightbridge Corporation is headquartered in Reston, Virginia.
LTBR Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong technical progress and a materially improved financial position, highlighted by the start of ATR irradiation testing, validated fabrication milestones, expanded INL scope and technical publications, and a cash balance that increased to $201.9 million (approximately +405% year-over-year) funded largely by a $176.0 million equity raise. At the same time, the company remains pre-commercial with significant regulatory, testing, and licensing work still required, used $14.3 million in operations in fiscal 2025, and faces timeline and execution risks tied to future post-irradiation examination and NRC engagement. Overall, positive execution and funding momentum outweigh near-term development and regulatory uncertainties.View all LTBR earnings summariesTechnical Analysis
Ownership Overview
5.30% Insiders
8.99% Mutual Funds
2.05% Other Institutional Investors
67.65% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---